This site is intended for Healthcare Professionals only

Johnson & Johnson

jj-1280

J&J adds infliximab and golimumab to its immunology portfolio

Johnson & Johnson today said it has taken on responsibility for the sales, marketing and distribution of the medicines in the UK.

17 Oct 2024 , 1 Min Article

Change privacy settings